Quercetin’s regulation of glucose and lipid metabolism in gestational diabetes mellitus: role of the PCSK9/LDLR axis
Open Access
- 24 November 2025
- journal article
- research article
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 22 (1)
Abstract
This study explored the ability of quercetin to improve glucose and lipid metabolism disorders induced by a high-fat diet (HFD) in a mouse model of gestational diabetes mellitus (GDM) on the basis of the PCSK9/LDLR axis and its potential molecular mechanisms. For the animal experiments, pregnant C57BL/6J mice were randomly divided into three groups: the control group (CD group), which was fed a standard diet; the model group (HFD group), which was fed a HFD; and the quercetin (CAS: 117–39–5) intervention group (HQ group), which was fed a HFD and given 75 mg·kg− 1·day− 1 quercetin by gavage. Moreover, we created an in vitro GDM hepatocyte model in which BNL CL.2 cells were cultured in high glucose and treated with 16 µM quercetin. The results showed that quercetin significantly improved glucose tolerance in GDM mice, reduced serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and proprotein convertase subtilisin/kexin type 9 (PCSK9) levels. It also alleviated hepatic steatosis and pancreatic islet cell hypertrophy. Additionally, it improved the abnormal weights of the placenta and fetus. In in vitro experiments, quercetin regulated the PCSK9/LDLR axis and activated the PI3K/AKT/GSK3β signaling pathway, increasing glucose uptake in liver cells. Molecular docking experiments confirmed that quercetin could directly occupy the PCSK9 catalytic pocket, with binding energies of -9.056 kcal mol− 1 for PCSK9 (human), -9. 193 kcal mol− 1 for PCSK9(mouse) and − 9.1 kcal mol− 1 for EGF-A interface of LDLR, which would sterically hinder LDLR interaction. This study revealed that quercetin improves glucose and lipid metabolism disorders in a GDM model by regulating the PCSK9/LDLR axis and the PI3K/AKT/GSK3β pathway. These findings support the potential use of quercetin as a treatment strategy for GDM.Keywords
Funding Information
- National Key Research and Development Program of China (No. 2021YFC2700700)
- Guangdong Basic and Applied Basic Research Foundation (No. 2022A1515111223)
- Scientific research project of Traditional Chinese Medicine Bureau of Guangdong Province (No. 20231057)
This publication has 50 references indexed in Scilit:
- Effect of (Poly)phenols on Lipid and Glucose Metabolisms in 3T3-L1 Adipocytes: an Integrated Analysis of Mechanistic ApproachesCurrent Obesity Reports, 2025
- Effects of Quercetin Metabolites on Glucose‐Dependent Lipid Accumulation in 3T3‐L1 AdipocytesMolecular Nutrition & Food Research, 2025
- Quercetin protects against neuronal toxicity by activating the PI3K/Akt/GSK-3β pathway in vivo models of MPTP-induced Parkinson’s diseaseInflammopharmacology, 2025
- Effect of Quercetin on Atherosclerosis Based on Expressions of ABCA1, LXR-α and PCSK9 in ApoE-/- MiceChinese Journal of Integrative Medicine, 2019
- Mice Fed a High‐Cholesterol Diet Supplemented with Quercetin‐3‐Glucoside Show Attenuated Hyperlipidemia and Hyperinsulinemia Associated with Differential Regulation of PCSK9 and LDLR in their Liver and PancreasMolecular Nutrition & Food Research, 2018
- Long-term Low-Density Lipoprotein Cholesterol–Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of HypercholesterolemiaJAMA Cardiology, 2017
- Quercetin oppositely regulates insulin‐mediated glucose disposal in skeletal muscle under normal and inflammatory conditions: The dual roles of AMPK activationMolecular Nutrition & Food Research, 2015
- Maternal quercetin administration during gestation and lactation decrease endoplasmic reticulum stress and related inflammation in the adult offspring of obese female ratsEuropean Journal of Nutrition, 2014
- Quercetin Reduces High‐Fat Diet‐Induced Fat Accumulation in the Liver by Regulating Lipid Metabolism GenesPhytotherapy Research, 2012
- Intrauterine exposure to high saturated fat diet elevates risk of adult‐onset chronic diseases in C57BL/6 miceBirth Defects Research Part B: Developmental and Reproductive Toxicology, 2009